Article
Prazosin for PTSD: Sorting out the evidence
- Author:
- Jenna Kendrick, PharmD
- Raechel Adamczyk, PharmD
- Christopher Thomas, PharmD, BCPS, BCPP
Mr. H, age 43, presents to your clinic for management of posttraumatic stress disorder (PTSD).
Article
Management of major depressive disorder with psychotic features
- Author:
- Rachel Barr, PharmD, BCPP
- Ben Miskle, PharmD
- Christopher Thomas, PharmD, BCPS, BCPP
Mrs. C, age 56, has a history of major depressive disorder (MDD).
Article
Antipsychotics for obsessive-compulsive disorder: Weighing risks vs benefits
- Author:
- Taylor Modesitt, PharmD
- Traci Turner, PharmD, BCPP
- Lindsay Honaker, DO
- Todd Jamrose, DO
- Elizabeth Cunningham, DO
- Christopher Thomas, PharmD, BCPS, BCPP
Consider the potential physical risks of long-term antipsychotic treatment, such as weight gain and extrapyramidal side effects.
News
When to adjust the dosing of psychotropics in patients with renal impairment
- Author:
- Sarah Ward, PharmD
- Julius Paul Roberts, DO
- William J. Resch, DO, DFAPA
- Christopher Thomas, PharmD, BCPS, BCPP